DEUTSCHE BANK AG\ - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$98,945
-19.7%
18,1550.0%0.00%
Q2 2023$123,273
+4.2%
18,155
-23.1%
0.00%
Q1 2023$118,351
+39.1%
23,623
+35.5%
0.00%
Q4 2022$85,068
-65.7%
17,432
+1.4%
0.00%
Q3 2022$248,000
-76.7%
17,186
-75.6%
0.00%
-100.0%
Q2 2022$1,064,000
-70.6%
70,336
-76.9%
0.00%
-50.0%
Q1 2022$3,624,000
+815.2%
305,042
+1150.1%
0.00%
Q4 2021$396,000
-39.4%
24,402
+6.8%
0.00%
Q3 2021$653,000
-31.0%
22,857
-18.4%
0.00%
Q2 2021$946,000
+17.4%
27,999
+5.0%
0.00%
Q1 2021$806,000
-43.7%
26,670
-7.8%
0.00%
-100.0%
Q4 2020$1,432,000
+67.9%
28,921
+30.2%
0.00%0.0%
Q3 2020$853,000
-27.6%
22,214
-18.6%
0.00%0.0%
Q2 2020$1,178,000
-17.3%
27,275
-50.0%
0.00%0.0%
Q1 2020$1,425,000
-71.7%
54,589
-66.1%
0.00%
-66.7%
Q4 2019$5,037,000
+3048.1%
161,249
+2498.7%
0.00%
Q3 2019$160,000
-56.5%
6,205
-61.5%
0.00%
Q2 2019$368,000
+61.4%
16,122
+83.7%
0.00%
Q1 2019$228,000
+19.4%
8,774
-7.2%
0.00%
Q4 2018$191,0009,4520.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders